TOVX

AMEX · Biotechnology

Theriva Biologics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.16

+0.01 (+4.35%)

TOVX News1 articles

Theriva Biologics Surges on Phase 1 Cancer Data, But Risks Remain

TOVX surged 74.6% on Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump is not based on approval or revenue.